Federal Judge Holds High-Stakes Hearings Today on Five Drug Industry 340B Rebate Lawsuits

U.S. District Judge Dabney Friedrich of the District of Columbia is presiding over five April 29 hearings over drugmaker 340B rebate lawsuits. She previously largely sided with Novartis and United Therapeutics in a separate case on drugmaker contract pharmacy restrictions.
A federal judge in Washington, D.C., is holding high-stakes hearings today on five drug industry lawsuits challenging the government’s opposition [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Audits Find Two Drugmakers Overcharged for 340B Drugs, Driving Calls for More Drug Industry Oversight 

HRSA released the results of its first two drugmaker audits of 2025 this month.
Recent Health Resources and Services Administration (HRSA) audits found that two drugmakers overcharged covered entities for their 340B drugs, fueling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Former 340B Health, Evernorth Executives Join Walgreens 

Greg Doggett and Ben Olson, two long-time executives in the 340B world, have recently taken on key positions at retail pharmacy giant Walgreens.
Two influential players in the 340B world have recently taken on key positions at retail pharmacy giant Walgreens, one of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Takeda Tightens 340B Contract Pharmacy Restrictions, Biogen Exempts Nebraska From Its Restrictions Policy

Japanese pharmaceutical giant Takeda recently announced changes to its 340B contract pharmacy restrictions.
A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Stakeholders React to HELP Committee Chair Cassidy’s 340B Probe Findings, Reform Recommendations

340B stakeholders offered mixed responses to the findings of U.S. Sen. Bill Cassidy's (R-La.) investigation into the 340B program.
340B hospitals, contract pharmacies, health center advocates and the drug industry offered mixed responses Thursday on the long-awaited findings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate HELP Committee Chair Cassidy Calls for Federal 340B Reforms, Releases Findings of Yearslong Congressional Probe

U.S. Sen. Bill Cassidy (R-La.) laid out a series of potential policies Congress could adopt to “bring much-needed reform to the 340B program” in a 195-page report, which summarized the findings of the investigation he launched in 2023—as the HELP panel’s top Republican—into how certain hospitals, health centers, chain pharmacies and drugmakers operate their 340B programs.
The leader of a key U.S. Senate Committee tasked with overseeing the 340B program called Thursday for Congress to improve [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Lobbying Remained Strong in Early 2025, Filings Show

Just over 300 firms listed the 340B program in their first quarter lobbying disclosure forms that were due April 21.
While much of the focus in Washington, D.C. has been on confirmation hearings and budget matters, the 340B program continued [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

As Trump Pharmaceutical Tariffs Loom, Drug Industry Pledges Investment in U.S. Manufacturing, Warns of Disruptions 

A recent survey of biotechnology firms reported that Trump's planned pharmaceutical tariffs would set back scientific innovation and reduce patients' access to medications.
The drug industry is bracing for the Trump administration’s planned tariffs on pharmaceutical products and ingredients, warning of supply chain [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health System CEOs Meet with RFK Jr. and Encourage Him to Preserve and Strengthen 340B at HHS Roundtable 

The CEOs of Cincinnati’s Bon Secours Mercy Health, Cleveland-based University Hospitals, Kansas-based HaysMed and Minnesota’s Riverwood Healthcare Center met with HHS Secretary Robert F. Kennedy Jr. last week. (Photo courtesy: Kennedy's X post.)
The leaders of four health systems recently met with Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Leaked HHS Budget Document Details Plans to Move 340B Program to CMS

The Trump administration appears to detail its plans to move the 340B program from HRSA to CMS in a reportedly leaked internal budget document.
President Donald Trump’s (R) preliminary budget appears to call for “new authority to regulate all aspects of the 340B program,” [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live